Loading…
ProQR Therapeutics is a biotechnology company focused on creating RNA therapies for patients with genetic disorders. Its proprietary Axiomer® technology uses RNA oligonucleotides to edit RNA, aiming to treat currently untreatable diseases.
AI named ProQR Therapeutics in January 2026.